Comparison of rapidly cycled tandem high-dose chemotherapy plus peripheral-blood stem-cell support versus dose-dense conventional chemotherapy for adjuvant treatment of high-risk breast cancer: results of a multicentre phase III trial
Author:
Ulrike Anneliese Nitz,Svjetlana Mohrmann,Johannes Fischer,Walter Lindemann,Wolfgang E Berdel,Christian Jackisch,Christoph Werner,Carsten Ziske,Hartmut Kirchner,Bernd Metzner,Rainer Souchon,Ute Ruffert,Gerhart Schütt,Anke Pollmanns et al.
Copyright © 2005 Elsevier Ltd. All rights reserved.